These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 12680624)

  • 21. Reduced leptin concentrations in subjects with type 2 diabetes mellitus in Sudan.
    Abdelgadir M; Elbagir M; Eltom M; Berne C; Ahrén B
    Metabolism; 2002 Mar; 51(3):304-6. PubMed ID: 11887164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is the defect in pro-hormone processing in Type 2 diabetes mellitus restricted to the beta cell?
    Bano G; Rodin DA; White A; O'Rahilly S; Nussey SS
    Diabet Med; 2001 Jan; 18(1):17-21. PubMed ID: 11168336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating proinsulin in patients with maturity onset diabetes.
    Mako ME; Starr JI; Rubenstein AH
    Am J Med; 1977 Dec; 63(6):865-9. PubMed ID: 343587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specific insulin and proinsulin in normal glucose tolerant first-degree relatives of NIDDM patients.
    Coifman R; Dalbosco IS; Russo EM; Moisés RS
    Braz J Med Biol Res; 1999 Jan; 32(1):67-72. PubMed ID: 10347771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Both fasting and glucose-stimulated proinsulin levels predict hyperglycemia and incident type 2 diabetes: a population-based study of 9,396 Finnish men.
    Vangipurapu J; Stančáková A; Kuulasmaa T; Kuusisto J; Laakso M
    PLoS One; 2015; 10(4):e0124028. PubMed ID: 25853252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of antihyperglycaemic therapies on proinsulin and relation between proinsulin and cardiovascular risk factors in type 2 diabetes.
    Hermann LS; Ranstam J; Vaaler S; Melander A
    Diabetes Obes Metab; 1999 Jul; 1(4):227-32. PubMed ID: 11228758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The relation of proinsulin, insulin, and proinsulin-to-insulin ratio to insulin sensitivity and acute insulin response in normoglycemic subjects.
    Mykkänen L; Haffner SM; Hales CN; Rönnemaa T; Laakso M
    Diabetes; 1997 Dec; 46(12):1990-5. PubMed ID: 9392485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Normal proinsulin responses to glucose in mild type II subjects with subnormal insulin response.
    Levy JC; Clark PM; Hales CN; Turner RC
    Diabetes; 1993 Jan; 42(1):162-9. PubMed ID: 8420813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of insulin resistance on proinsulin secretion in pregnancy: hyperproinsulinemia is not a feature of gestational diabetes.
    Retnakaran R; Hanley AJ; Sermer M; Zinman B
    Diabetes Care; 2005 Nov; 28(11):2710-5. PubMed ID: 16249544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sulfonylurea-metformin-combination versus sulfonylurea-insulin-combination in secondary failures of sulfonylurea monotherapy. Results of a prospective randomized study in 50 patients.
    Klein W
    Diabete Metab; 1991 May; 17(1 Pt 2):235-40. PubMed ID: 1936483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of gliclazide on plasma insulin, intact and 32/33 split proinsulin in South Asian subjects with Type 2 diabetes mellitus.
    Ammari F; Davies MJ; Koppiker N; Gregory R; Burden AC
    Diabet Med; 1999 Feb; 16(2):142-6. PubMed ID: 10229308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of glucagon-like peptide 1 on fasting glycemia in type 2 diabetic patients treated with insulin after sulfonylurea secondary failure.
    Nauck MA; Sauerwald A; Ritzel R; Holst JJ; Schmiegel W
    Diabetes Care; 1998 Nov; 21(11):1925-31. PubMed ID: 9802745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin deficiency rather than hyperinsulinaemia in newly diagnosed type 2 diabetes mellitus.
    Davies MJ; Metcalfe J; Gray IP; Day JL; Hales CN
    Diabet Med; 1993 May; 10(4):305-12. PubMed ID: 8508611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pancreatic B-cell function in non-insulin-dependent diabetes mellitus during successive periods of sulfonylurea and insulin treatment: serum C-peptide response to glucagon and urine C-peptide excretion.
    Hsieh SD; Iwamoto Y; Matsuda A; Kuzuya T
    Endocrinol Jpn; 1987 Aug; 34(4):561-7. PubMed ID: 3315640
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Choice of treatment affects plasma levels of insulin-like growth factor-binding protein-1 in noninsulin-dependent diabetes mellitus.
    Gibson JM; Westwood M; Crosby SR; Gordon C; Holly JM; Fraser W; Anderson C; White A; Young RJ
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1369-75. PubMed ID: 7536208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acarbose vs. bedtime NPH insulin in the treatment of secondary failures to sulphonylurea-metformin therapy in type 2 diabetes mellitus.
    López-Alvarenga JC; Aguilar-Salinas CA; Velasco-Perez ML; Arita-Melzer O; Guillen LE; Wong B; Brito G; Mercado V; Gómez-Pérez FJ; Rull-Rodrigo JA
    Diabetes Obes Metab; 1999 Jan; 1(1):29-35. PubMed ID: 11221809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of genetic predisposition on proinsulin responses in Asian Indians.
    Ramachandran A; Snehalatha C; Satyavani K; Vijay V
    Diabetes Res Clin Pract; 1998 Jul; 41(1):71-7. PubMed ID: 9768375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological PPARgamma stimulation in contrast to beta cell stimulation results in an improvement in adiponectin and proinsulin intact levels and reduces intima media thickness in patients with type 2 diabetes.
    Forst T; Hohberg C; Fuellert SD; Lübben G; Konrad T; Löbig M; Weber MM; Sachara C; Gottschall V; Pfützner A
    Horm Metab Res; 2005 Aug; 37(8):521-7. PubMed ID: 16138267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma insulin, C-peptide, and proinsulin concentrations in obese and nonobese individuals with varying degrees of glucose tolerance.
    Reaven GM; Chen YD; Hollenbeck CB; Sheu WH; Ostrega D; Polonsky KS
    J Clin Endocrinol Metab; 1993 Jan; 76(1):44-8. PubMed ID: 8421101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced pancreatic B cell compensation to the insulin resistance of aging: impact on proinsulin and insulin levels.
    Røder ME; Schwartz RS; Prigeon RL; Kahn SE
    J Clin Endocrinol Metab; 2000 Jun; 85(6):2275-80. PubMed ID: 10852463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.